On April 14, 2026, Twelve UBC ventures will be taking the stage at Innovation UBC's 2026 Investor Showcase. This year's teams span four broad areas: health and digital therapeutics, medical devices and diagnostics, AI and deep tech, and clean materials and biotech. Together, they represent the breadth and quality of research translation emerging from UBC's Faculties of Applied Science, Medicine, Science, and Land and Food Systems.
The Investor Showcase is one of our flagship events connecting investors with high-potential UBC ventures raising Seed to Series A rounds. Held each spring at UBC Robson Square, the evening features back-to-back pitches and networking — a must-attend for anyone looking to connect early with the next generation of companies emerging from one of the world's top research universities.
Every presenting venture has been built through Innovation UBC's Venture Founder or HATCH Venture Builder programs, our structured pathways for UBC researchers, students, and staff to translate deep expertise into IP-based, commercially viable companies. Each was then selected for the showcase through a competitive evaluation process with an expert committee that included Andrea Barrios (Senior Associate, Sandpiper Ventures), Allison Gaw (Principal, Amplitude Ventures), Hans Knapp (Partner, Yaletown Partners), and Martin Smith (Associate, Osler, Hoskin & Harcourt LLP).
Register for Investor Showcase
Registered investors will receive detailed one-pagers on each presenting venture, including their investment asks, in advance of the event.
Featured ventures
Dream Photonics
Producing scalable ultra-low loss optical interconnects for AI data centers
- UBC Affiliation: Faculty of Applied Science, Department of Electrical and Computer Engineering
- Website: www.dreamphotonics.com
Dream Photonics is revolutionizing the integrated photonics packaging industry – we develop the manufacturing processes and software required to support the explosive growth in AI. Our adaptive 3D-printed optics enable an electronics-style assembly process, replacing the incumbent "artisanal" active alignment processes with higher yield, higher manufacturing throughput, at lower cost. Our technology is used to build optical fiber communication link modules consisting of multiple efficiently-coupled photonic chips including lasers, modulators and detectors, increasing data center energy efficiency.
Carbonyx Minerals
Transforming industrial waste and captured carbon into sustainable, high-value materials
- UBC Affiliation: Faculty of Science, Department of Chemistry
- Website: www.carbonyx.com
Traditional carbon capture and storage methods face significant adoption hurdles and challenging paths to profitability due to a reliance on unpredictable carbon credit markets and volatile government policy. Carbonyx addresses this profitability gap by utilizing an electrochemical process that transforms CO₂ and industrial waste into high-purity silica and captured carbon. By retooling commercial water electrolyzers to process waste and capture carbon, our technology creates a decentralized silica production model that drastically reduces shipping costs and embodied emissions. This approach ensures profitability and permanent carbon sequestration by turning environmental liabilities into sustainable, high-value products.
Haibu Health
Unifying diabetes data into actionable insights that prevent crises and keep patients healthy
- UBC Affiliation: Faculty of Medicine, Department of Pediatrics
- Website: www.haibuhealth.com
Haibu Health unifies diabetes data from wearables and health systems and uses predictive AI to generate actionable insights, helping patients and clinicians act before crises happen. Imagine an 'all-in-one' digital place where patients, caregivers and clinicians can view data, communicate and collaborate while also receiving actionable alerts like, 'your glucose trends are changing, let's adjust now.' Or, a dashboard where clinicians can easily identify patients at risk for poor outcomes so they can deliver the right care to the right patient at the right time. Haibu Health strives for a world where health care is proactive, not reactive, and where data fulfills its promise, to keep people living with chronic disease healthy and happy.
Radiant Fluidics
Automated radiochemistry platform accelerating radiopharmaceutical development and clinical translation
- UBC Affiliation: Faculty of Applied Science, Department of Engineering; Faculty of Medicine, Department of Radiology
- Website: https://radiantfluidics.com/
Radiopharmaceutical development is often performed manually in early stages and later rebuilt on rigid automated systems used for clinical production, which creates delays, documentation gaps, and expensive rework. Radiant Fluidics is building an automated radiochemistry platform that enables teams to develop processes earlier with traceability and repeatability, then translate to clinical-grade workflows without redesign. The platform combines hardware, disposable workflow cassettes, and software that captures run history and supports regulatory documentation. The company's mission is to provide developer-first automation that helps accelerate time-to-clinic and de-risks translation for emerging radiopharmaceuticals.
CheckMark
Faster skin cancer diagnosis through pharmacy-based imaging and dermatologist review
- UBC Affiliation: Faculty of Medicine, Department of Medicine
- Website: https://www.check-mark.ca/
CheckMark helps people quickly find out whether a concerning skin spot might be cancer. Right now, patients often wait months to see a dermatologist, even though many spots turn out to be harmless. We place high-quality skin imaging in convenient locations like pharmacies and have real dermatologists review the images within days. Benign spots are reassured quickly, and suspicious lesions are fast-tracked directly into the healthcare system for biopsy or treatment—cutting wait times, reducing anxiety, and catching cancers earlier.
Promirin Therapeutics
Precision medicines for all cancer patients through transient molecular switches
- UBC Affiliation: Faculty of Medicine
- Website: www.promirin.com
Half of us will be directly affected by cancer in our lifetime with 25% of these cases gastrointestinal in origin, losing 1 million of our friends and family yearly in North America. Targeted therapies that act on cancer-specific mutations can be effective in significantly changing survival outcomes. However, the vast majority of us, some 86% will not be suitable, lacking the required mutations to enable their use. At Promirin, we have developed a novel platform that links the native gears of cancer cells with the production of artificial RNA suppressors capable of hindering the action of any specified cancer-causing gene. Our transient molecular switch platform acts in a cell specific manner sparing healthy cells from off-target effects.
Sustainable Bioproduct Innovations (SBI)
Driving the transition from unhealthy fats through the science of plant-fibre
- UBC Affiliation: Faculty of Land and Food Systems
- Website: http://www.sbinnovations.net/
Sustainable Bioproduct Innovations Inc. (SBI) is a New Westminster-based biotech firm specializing in the "Fat Transition." Our flagship product, 0Fat™, is a patented, plant-based fat mimetic that allows food manufacturers to replace traditional fats (butter, oils, lard) with a clean-label, high-fiber alternative. With the rise of front-of-pack labeling, GLP-1 medications and a global obesity crisis, CPG companies are under immense pressure to reformulate. 0Fat™ provides the solution: an 80% increase in fiber (per replaced gram) and up to a 77% reduction in saturated fat, all while lowering the manufacturer's COGS and shipping weight.
Sonus Microsystems
Operator-independent ultrasound for accessible cardiac monitoring anywhere
- UBC Affiliation: Faculty of Applied Science, Department of Electrical and Computer Engineering
- Website: https://www.sonusmicrosystems.com/
Sonus is developing an automated ultrasound patch that enables fast, repeatable cardiac and hemodynamic assessment without requiring ultrasound expertise. Today, access to echocardiography is limited by scarce sonographers, centralized equipment, and scheduling delays, leaving many patients without timely monitoring. Our large-area, solid-state ultrasound array standardizes image acquisition, allowing non-expert staff to capture image-backed measurements at the point of care or in the home. By combining hardware innovation with AI-guided quality control and remote review capability, Sonus makes cardiac monitoring more accessible, scalable, and consistent.
eSense Health
A clinically validated self-directed digital therapeutic for female sexual dysfunction
- UBC Affiliation: Faculty of Medicine, Department of Obstetrics and Gynaecology
- Website: www.esensehealth.com
Female sexual dysfunction affects up to 40% of women, yet fewer than 20% receive treatment due to cost, stigma, and limited access to trained specialists. eSense is a clinically validated digital therapeutic that translates gold-standard psychological treatments—cognitive behavioral therapy and mindfulness—into a structured, self-guided online program. Backed by randomized controlled trial data demonstrating outcomes comparable to in-person therapy, eSense delivers evidence-based care in a private, affordable, and scalable format. Our technology expands access to treatment-level support for millions of women who would otherwise go untreated.
VibeOps Technologies
Automating engineering report formatting so engineers can focus on engineering
- UBC Affiliation: Faculty of Applied Science, Department of Civil Engineering; Faculty of Science, Department of Computer Science
- Website: https://www.vibeops.ca/
VibeOps is an AI-powered automation platform that streamlines technical report generation for civil engineering firms. Engineering teams spend 30–40% of project time preparing repetitive documentation for compliance, permitting, and client reporting, which reduces billable efficiency and slows project delivery. Our technology integrates structured customer data with their own templates to automatically generate accurate, formatted, and regulation-ready reports in minutes instead of days. By eliminating manual formatting and repetitive writing, VibeOps allows firms to scale operations, reduce overhead, and focus on high-value design and field work.
Resolve Nanotherapeutics
Novel broad-spectrum drugs for acute bacterial infections
- UBC Affiliation: Faculty of Medicine
- Website: https://resolventx.com/
We are developing completely new drugs that have huge potential to reduce death and morbidity outcomes from severe infections including pneumonia, sepsis and others. The need is great as frontline treatments are primarily antibiotics, which are becoming ineffective due to the rampant spread of antibiotic resistance genes in bacteria and even new antibiotics are used sparingly. Our drugs function completely differently by turning up patients' natural immunity to these infections with clinically validated and safe gene targets; they are organism and antibiotic resistance agnostic and will thus be broadly protective. The Resolve NTx drugs have the potential to reduce the number of deaths from sepsis alone by half, saving millions of lives per year and reducing the economic/healthcare and social burden of the poor outcomes of these severe infections.
Tydra Labs
Transforming waste into high-performance sustainable materials using engineered biology
- UBC Affiliation: Faculty of Applied Science, Department of Chemical and Biological Engineering
- Website: www.tydralabs.com
Tydra Labs is a biotechnology company engineering bacteria to convert crustacean and other organic waste into high-performance, sustainable biomaterials. Today, most chitin and advanced materials are derived through chemically intensive, water-heavy processes or petroleum-based alternatives. Our proprietary platform enables clean, scalable extraction and transformation of waste streams into value-added materials for agriculture, packaging, and advanced materials applications. By aligning engineered biology with circular manufacturing, we are building the next generation of bio-based materials infrastructure.
Join us at Innovation UBC's 2026 Investor Showcase
Join us Tuesday, April 14, 2026, at UBC Robson Square for an evening of pitches and connections with UBC's most investor-ready ventures.
About Innovation UBC
Innovation UBC is a service-oriented unit dedicated to enabling UBC researchers and students to translate their work into societal and economic impact.
Innovation UBC works with UBC’s researchers to support and accelerate the translation of their research into real world impacts. Through research partnerships, technology transfer, and venture building services, UBC researchers have access to a robust ecosystem of services and support to strengthen their translation opportunities. Our successful history of translation and commercialization has led to the creation of 284 spin-off companies, establishing over 500 active licensing agreements, and enabling thousands of research partnerships each year with industry, government, and non-profit organizations. We support $190M+ annually in sponsored research activities (which is more than 80% of provincial sponsored research funding). UBC licensed technologies have attracted over $8.4 billion in investment capital and generated over $13 billion in revenues. 91% of UBC spin-off companies remain in Canada, 88% in BC. Our mission is to help create impact from UBC’s breakthrough research to generate social, health, environmental and economic benefits.
